The House of Commons Health Select Committee, in its report on NICE, stated in 2008 that " the (...) cost-per-QALY it uses to decide whether a treatment is cost-effective is of serious concern.

Due to a lack of data, The NICE Guidelines for the Treatment and Management of Adult Depression ( 2009 ) issued no updated treatment recommendation for the use of maintenance or relapse prevention ECT.

Now with the ability to grant a B. Ed., school leaders took it upon themselves to use the name North Idaho College of Education ( NICE ).

Currently, the National Institute for Health and Clinical Excellence ( NICE ) of England ’ s National Health Service ( NHS ) uses cost-effectiveness studies to determine if new treatments or therapies provide better value relative to the treatment that is currently in use.

In 2004, the British National Health Service's National Institute for Health and Clinical Excellence ( NICE ) considered a systematic review of four randomized controlled trials before issuing guidelines for the use of LASIK within the NHS.

All these are drugs with a high cost per treatment and NICE has either rejected or restricted their use in the NHS on the grounds that they are not cost-effective.

In June 2006, the UK Advertising Standards Authority ( ASA ) upheld the complaint by NICE and ruled that the use of the quote was in breach of ASA guidelines.

According to National Institute for Health and Clinical Excellence ( NICE ), benzodiazepines can be used in the immediate management of GAD, if necessary.

NICE review pointed out that short-acting Z-drugs were inappropriately compared in clinical trials with long-acting benzodiazepines.

Guidelines issued by the UK-based National Institute for Health and Clinical Excellence ( NICE ), carried out a systematic review using different methodology and came to a different conclusion.

The only medications NICE recommends for the longer term management of GAD are antidepressants.

In the United Kingdom, the National Institute for Health and Clinical Excellence ( NICE ) recommends CBT in the treatment plans for a number of mental health difficulties, including posttraumatic stress disorder, obsessive – compulsive disorder ( OCD ), bulimia nervosa, and clinical depression.

NICE said that CBT would become the mainstay of treatment for non-severe depression, with medication used only in cases where CBT had failed.

The UK's National Institute for Health and Clinical Excellence ( NICE ) guidelines recommend ECT for patients with severe depression, catatonia, or prolonged or severe mania.

The 2003 NICE ECT guidelines do not recommend ECT for schizophrenia, and this has been supported by meta-analytic evidence showing no or little benefit versus placebo, or in combination with antipsychotic drugs, including Clozapine.

The NICE 2003 guidelines state that doctors should be particularly cautious when considering ECT treatment for women who are pregnant and for older or younger people, because they may be at higher risk of complications with ECT.

The National Institute for Health and Clinical Excellence ( NICE ), UK released updated diabetes recommendations on the 30th May 2008, which recommend that self-monitoring of plasma glucose levels for people with newly diagnosed type 2 diabetes must be integrated into a structured self-management education process.

Opponents of the current reform care proposals fear that U. S. comparative effective research ( a plan introduced in the stimulus bill ) will be used to curtail spending and ration treatments, which is one function of NICE, arguing that rationing by market pricing rather by government is the best way for care to be rationed.

The chief executive of the National Institute for Health and Clinical Excellence ( NICE ), told The Guardian newspaper that " it is neither true, nor is it anything you could extrapolate from anything we've ever recommended " that Kennedy would be denied treatment by the NHS.

Even the NICE criteria for public funding of medical treatments were never set by politicians.

Because of the weakness of the evidence and the potential for serious side effects from some drug therapies, the UK National Institute for Health and Clinical Excellence ( NICE ) 2009 clinical guideline for the treatment and management of BPD recommends: " Drug treatment should not be used specifically for borderline personality disorder or for the individual symptoms or behaviour associated with the disorder " but " drug treatment may be considered in the overall treatment of comorbid conditions ," and suggests " review of the treatment of people with borderline personality disorder who do not have a diagnosed comorbid mental or physical illness and who are currently being prescribed drugs, with the aim of reducing and stopping unnecessary drug treatment.

In the UK, the NICE guidelines define infertility as failure to conceive after regular unprotected sexual intercourse for 2 years in the absence of known reproductive pathology.

However NICE has recommended that there should be further research of CAT, for example in Borderline personality disorder.

It was set up as the National Institute for Clinical Excellence in 1999, and on 1 April 2005 joined with the Health Development Agency to become the new National Institute for Health and Clinical Excellence ( still abbreviated as NICE ).

NICE also plays an important role in pioneering technology assessment in other healthcare systems through NICE International, established in May 2008 to help cultivate links with foreign governments.

Once this has been done NICE works with the Department of Health to draw up the scope of the appraisal.

As a guideline rule, NICE accepts as cost effective those interventions with an incremental cost-effectiveness ratio of less than £ 20, 000 per QALY and that there should be increasingly strong reasons for accepting as cost effective interventions with an incremental cost-effectiveness ratio of over a threshold of £ 30, 000 per QALY.

NICE is often associated with controversy, because the need to make decisions at a national level can conflict with what is ( or is believed to be ) in the best interests of an individual patient.

For example the NHS usually pays for several rounds of treatment for fertility problems but because NICE has not assessed them some PCTs may cap the number of rounds and the patient may then have to pay privately if he or she wished to continue with fertility treatments beyond the capped level.

The NICE report concluded that women who give birth at home are more likely to deliver vaginally and to have greater satisfaction from the experience when compared with women who plan to give birth in a hospital.

* ACerS-American Ceramic Society with their National Institute of Ceramic Engineers ( NICE )

Antibiotics are administered to patients with certain heart conditions as a precaution, although this practice has changed in the US, with new American Heart Association guidelines released in 2007, and in the UK as of March 2008 due to new NICE guidelines.

NICE is therefore applying the same market pricing principles to make the hard job of deciding between funding some treatments and not funding others on behalf of everyone in the insured pool.

In Europe's largest health market Germany the Institute for Quality and Economy in Health Services ( Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen-IQWiG ) is responsible, while it is the National Institute for Health and Clinical Excellence NICE in the United Kingdom.

The National Institute for Health and Clinical Excellence ( NICE ) is a special health authority of the English National Health Service ( NHS ), serving both English NHS and the Welsh NHS.

This is submitted to NICE for approval.

This is submitted to NICE who then formally approve the guideline and issues this guidance to the NHS.

In practice this exercise is not done, but an assumed shadow price has been used by NICE for many years in its assessments to determine which treatments the NHS should and should not fund.

NICE states that for drugs the cost per QALY should not normally exceed £ 30, 000 but that there is not a hard threshold, though research has shown that any threshold is " somewhat higher " than being in the range £ 35, 000-£ 40, 000.

The threshold it employs is not based on empirical research and is not directly related to the NHS budget, nor is it at the same level as that used by Primary Care Trusts ( PCTs ) in providing treatments not assessed by NICE, which tends to be lower.

The work that NICE is involved in attracts the attention of many groups, including doctors, the pharmaceutical industry, and patients.